Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Donald Hohman

Adult Reconstructive Orthopaedic Surgery Dallas, TX Medical Doctor

NPI 1801235833 CMS profile 354332

7777 Forest Ln Ste C106, Dallas, TX 75230

Open in the dashboard

General payments

$537,406

410 records reported · program years 2019–2025

Research payments

$13,700

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$488,110 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Donald Hohman of Dallas, TX is reported in the CMS Open Payments database as having received $537,406 across 410 general payments and $13,700 in research payments paid to them. Separately, studies naming them as principal investigator received $488,110 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $51,266 17
2024 General $35,719 42
2023 General $42,201 47
2022 General $46,401 58
2021 General $128,260 81
2021 Research $1,080 1
2020 General $88,534 50
2020 Research $12,620 3
2019 General $145,026 115

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Donald Hohman
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Donald Hohman were reported at $51,266. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Donald Hohman Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $145,026 $1,416 $292–$9,336 $163
2020 $88,534 $647 $141–$6,474 $114
2021 $128,260 $1,073 $211–$6,497 $132
2022 $46,401 $1,217 $236–$6,299 $149
2023 $42,201 $1,082 $246–$6,818 $160
2024 $35,719 $1,575 $323–$8,944 $164
2025 $51,266 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sanara MedTech Inc. $104,290 73 payments
  2. Limacorporate S.p.A. $85,706 34 payments
  3. Advanced Orthopaedic Solutions, Inc. $79,366 24 payments
  4. Arthrex, Inc. $56,926 8 payments
  5. Encore Medical, LP $43,053 52 payments
  6. Kyocera Medical Technologies, Inc. $29,818 11 payments
  7. Lima USA, Inc. $23,525 24 payments
  8. Orthalign Inc $21,696 47 payments
  9. Signature Orthopaedics USA Corp $19,437 2 payments
  10. Medical Device Business Services, Inc. $16,254 13 payments
  11. Other $57,336 122 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $347,352 127 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $87,975 27 payments
  3. Travel and Lodging $66,738 87 payments
  4. Royalty or License $19,437 2 payments
  5. Food and Beverage $12,600 164 payments
  6. Debt forgiveness $2,490 1 payment
  7. Honoraria $700 1 payment
  8. Gift $114 1 payment
Products named General payments · program years 2019–2025
  1. CellerateRx $111,131 76 payments
  2. Physica $99,831 52 payments
  3. AOS PRODUCTS $50,966 20 payments
  4. DJO Surgical TaperFill Hip System $36,945 25 payments
  5. Trochanteric Nail $28,400 4 payments
  6. DJO Surgical Empowr Knee System $22,706 20 payments
  7. OrthAlign Plus System $17,091 35 payments
  8. UMS U3 $9,696 1 payment
  9. PHYSICA CR $9,400 6 payments
  10. Biasurge $4,261 3 payments
  11. Other $37,624 170 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. OMNIlife science, Inc $13,700 4 payments

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

468

Median for Orthopedic Surgery: 203

Drug cost

$3,527

Median for Orthopedic Surgery: $1,433

Branded share of claims

5.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 74 $1,806
Gabapentin Generic 93 $490
Oxycodone Hcl Generic 72 $414
Tramadol Hcl Generic 73 $316
Ondansetron Hcl Generic 85 $255
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 13 $116
Amoxicillin Generic 47 $71
Ondansetron Odt Ondansetron Brand 11 $58

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 142 billing codes

Paid by Medicare

$333,760

Of which drugs: $10,220

Medicare patients

600

Average age 76

Services billed

4,541

392 women, 208 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 30%
Depression 30%
Diabetes 26%
Osteoporosis 25%
Chronic kidney disease 24%
Atrial fibrillation 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg J7318 Office 23 1,866 $9,379
Injection, methylprednisolone acetate, 40 mg J1030 Office 36 60 $267
Injection, methylprednisolone acetate, 1 mg J1010 Office 96 184 $20

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
CALDOLOR
  • Cumberland Pharmaceuticals, Inc. $14
$14 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

414 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record